EVAX Evaxion
NEUTRAL
Impact: 3/10
PRESS-RELEASE
Press release: announcement
Latest settled — T+20d ⚠ clustered
EVAX ▼ -1.67% at T+20d
NEUTRAL call ✗ call lost -1.67% · α vs SPY -6.63% · entry $4.18 → $4.11
Last close $3.73 (close Jun 8) · -10.77% from $4.18 entry
T+1d
+3.35%
call +3.35% · α +3.83%
$4.32
settled 6w ago
T+5d
+9.33%
call +9.33% · α +8.93%
$4.57
settled 5w ago
T+20d
-1.67%
call -1.67% · α -6.63%
$4.11
settled 15d ago
T+60d
—
call — · α —
—
in 6w
Price Chart
Loading chart...
Executive Summary
Evaxion promoted its Chief Scientific Officer, Birgitte Rønø, to also serve as Chief Operating Officer to enhance external engagement and strategic execution. The move reflects internal management restructuring but does not involve new financial or operational data.
Actionable Insight
Monitor upcoming 10-Q or 20-F filings for any changes in R&D or G&A spending that may reflect the expanded management role. No immediate trading catalyst present.
Key Facts
- Birgitte Rønø, CSO, promoted to dual role of CSO and COO at Evaxion
- Promotion aims to strengthen external visibility and strategic execution of the AI-Immunology™ platform
- No changes to other executive roles; management team remains intact
- No financial metrics, guidance updates, or material operational changes disclosed
Financial Impact
No immediate financial impact — organizational change without cost or revenue implications disclosed
operating_efficiencymanagement_structure
Risk Factors
- Potential operational disruption during leadership transition, though risk appears low given internal promotion
- Forward-looking statements carry uncertainty regarding future partnerships and platform visibility
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3281538 |
19 reports for EVAX
100%
Hit rate
best @ T+5▲ +22.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 12, 2026
28d ago
|
6-K
| $4.17 $4.09 | ▼ −1.92% | ▼ −2.00% | $3.73 (−10.55%) |
|
May 12, 2026
28d ago
|
Press Release
| $4.17 $4.09 | ▼ −1.92% | ▼ −2.00% | $3.73 (−10.55%) |
|
May 7, 2026
4w ago
|
6-K
| $4.07 $4.16 | ▲ +2.21% | ▲ +0.71% | $3.73 (−8.35%) |
|
May 4, 2026
5w ago
|
Press Release
| $4.57 $4.23 | ▼ −7.55% | ▼ −10.49% | $3.73 (−18.38%) |
|
Apr 27, 2026
6w ago
|
6-K
| $4.18 $4.57 | ▲ +9.33% | ▲ +8.93% | $3.73 (−10.77%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $4.18 $4.57 | ▲ +9.33% | ▲ +8.93% | $3.73 (−10.77%) |
|
Apr 22, 2026
6w ago
|
6-K
| $4.27 $4.27 | · 0.00% | ▼ −0.05% | $3.73 (−12.65%) |
|
Apr 17, 2026
7w ago
|
6-K
| $4.45 $4.03 | ▼ −9.44% | ▼ −9.99% | $3.73 (−16.18%) |
|
Apr 17, 2026
7w ago
|
6-K
| $4.45 $4.03 | ▼ −9.44% | ▼ −9.99% | $3.73 (−16.18%) |
|
Apr 17, 2026
7w ago
|
Press Release
| $4.45 $4.03 | ▼ −9.44% | ▼ −9.99% | $3.73 (−16.18%) |
Showing 10 of 19
US Market Status
Market Closed — Opens in 8h 59m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access